Entegrion
Entegrion is a life sciences company dedicated to providing innovative solutions to improve clinicians’ ability to effectively manage hemostasis in patients. They develop patented technologies to overcome limitations in storage, safety, and availability of blood-derived products, collaborating with leading medical research institutions. Their products are designed for both civilian and military medicine, with significant funding from the U.S. Department of Defense. Entegrion's focus includes developing blood products like Resusix™ and diagnostic systems such as the Point of Care Coagulation Monitoring system, aiming to enhance patient outcomes in various clinical settings.
Industries
Nr. of Employees
small (1-50)
Entegrion
Durham, North Carolina, United States, North America
Products
Portable viscoelastic coagulation monitoring system
A portable, near-patient viscoelastic testing instrument that provides automated, real-time assessment of whole-blood coagulation without reagents or sample pre-treatment; designed for emergency, surgical, critical care, and pre-hospital use. CE marked for sale in regions accepting the CE mark.
Dehydrated pathogen-reduced human plasma for transfusion
Spray-dried, solvent-detergent–treated dehydrated human plasma product designed to serve as a substitute for fresh frozen plasma in certain clinical applications; developed to reduce infectious risk and enable extended shelf life and deployability.
Freeze-dried platelet-derived hemostatic agent
A shelf-stable, freeze-dried hemostatic product derived from platelets intended for rapid rehydration and infusion to treat bleeding due to low platelet counts or dysfunction (preclinical development described).
Portable viscoelastic coagulation monitoring system
A portable, near-patient viscoelastic testing instrument that provides automated, real-time assessment of whole-blood coagulation without reagents or sample pre-treatment; designed for emergency, surgical, critical care, and pre-hospital use. CE marked for sale in regions accepting the CE mark.
Dehydrated pathogen-reduced human plasma for transfusion
Spray-dried, solvent-detergent–treated dehydrated human plasma product designed to serve as a substitute for fresh frozen plasma in certain clinical applications; developed to reduce infectious risk and enable extended shelf life and deployability.
Freeze-dried platelet-derived hemostatic agent
A shelf-stable, freeze-dried hemostatic product derived from platelets intended for rapid rehydration and infusion to treat bleeding due to low platelet counts or dysfunction (preclinical development described).
Services
Government-funded clinical development and program management
Management and execution of defense- and government-funded product development programs, including contract deliverables, coordination with research institutions, and clinical study support.
Government-funded clinical development and program management
Management and execution of defense- and government-funded product development programs, including contract deliverables, coordination with research institutions, and clinical study support.
Expertise Areas
- Point-of-care coagulation diagnostics
- Transfusion product development
- Pathogen-reduction and plasma processing
- Clinical trial execution for biologics (IND through Phase 3)
Key Technologies
- Viscoelastic coagulation testing
- Reagent-free whole-blood diagnostics
- Spray-drying of plasma
- Solvent-detergent pathogen reduction